Literature DB >> 10822219

Somatic trinucleotide change encompassing codons 882 and 883 of the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma.

M J Bugalho1, I Coelho, L G Sobrinho.   

Abstract

OBJECTIVE: Restriction analysis is a straightforward procedure for mutational analysis. It is commonly used for screening RET mutations. Incomplete digestion is a well-known cause of false results. Herein, we report another limitation of the method. DESIGN AND METHODS: Screening for somatic mutations in RET exons 16, 13 and 15 was performed in a patient with a sporadic medullary thyroid carcinoma. Genetic study was carried out by both restriction analysis and direct sequencing.
RESULTS: A somatic trinucleotide change encompassing codons 882 and 883 of the RET proto-oncogene (GTA GCT to GTT TTT) was documented. Particular to this case is the silent mutation (GTA-->GTT) at codon 882. Independently, both the novel silent mutation and the missense mutation at codon 883 may disrupt the same AluI restriction site. Based on the restriction pattern we were able to say that both mutations occurred in the same allele.
CONCLUSIONS: Restriction analysis is an easy approach for screening RET mutations; however, it is not enough to assign a final diagnosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822219     DOI: 10.1530/eje.0.1420573

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  3 in total

Review 1.  Molecular genetics of thyroid cancer.

Authors:  Maha Rebaї; Ahmed Rebaї
Journal:  Genet Res (Camb)       Date:  2016-05-13       Impact factor: 1.588

2.  The newly detected mutations in the RET proto-oncogene in exon 16 as a cause of sporadic medullary thyroid carcinoma.

Authors:  S Jindrichova; R Kodet; L Krskova; P Vlcek; B Bendlova
Journal:  J Mol Med (Berl)       Date:  2003-11-15       Impact factor: 4.599

3.  Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas.

Authors:  M M Moura; B M Cavaco; A E Pinto; R Domingues; J R Santos; M O Cid; M J Bugalho; V Leite
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.